Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining

被引:13
|
作者
Luo, Jiao [1 ]
Zhang, Wang [1 ]
Su, Cailing [1 ]
Zhou, Zhanmei [1 ]
Wang, Guobao [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Renal Div,State Key Lab Organ Failure Res, Guangzhou, Peoples R China
关键词
PLA2R antibody; PLA2R antigen; PLA2R-associated MN; renal pathologic chronicity lesions; PHOSPHOLIPASE-A2 RECEPTOR AUTOANTIBODIES; ANTI-PLA(2)R AUTOANTIBODIES; GLOMERULAR DEPOSITS; KIDNEY BIOPSY; ANTIBODIES; DIAGNOSIS; ANTIGEN;
D O I
10.1093/ndt/gfaa239
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Serum phospholipase A2 receptor (PLA2R) anti-body (SAb) and glomerular deposits of PLA2R antigen (GAg) have been tested widely in idiopathic membranous nephropathy (MN). Recently, we noticed a special form of PLA2R-associated MN with positive circulating PLA2R antibody but negative PLA2R deposits in the glomeruli by immunofluorescence on frozen tissue (IF-F). The significance of this form of PLA2R-associated MN is yet to be elucidated. This study aimed to explore the clinicopathological features of these PLA2R-associated MN patients. Methods. This study enrolled 229 biopsy-proven PLA2R-associated MN patients with SAb+. SAb was measured by enzyme-linked immunosorbent assay, and GAg was detected by IF-F. These patients were divided into SAb+/GAg+ and SAb+/GAg- groups. Clinicopathological characteristics of SAb+/GAg+ and SAb+/GAg- PLA2R-associated MN patients were compared. PLA2R antigens of 19 SAb+/GAg- PLA2R-associated MN patients were verified by immunohistochemistry on paraffin tissue (IHC-P). Results. Among 229 SAb+ PLA2R-associated MN patients, 210 (91.70%) were GAg+ and 19 (8.3%) were GAg-. These 19 SAb+/GAg- PLA2R-associated MN patients presented positive PLA2R deposits by IHC-P. Compared with SAb+/GAg+ PLA2R-associated MN patients, SAb+/GAg- PLA2R-associated MN patients had higher levels of serum PLA2R anti-body (P = 0.004), increased proteinuria (P = 0.008), lower serum albumin (P = 0.019), more prominent chronic pathological lesions in terms of glomerulosclerosis score (P = 0.025), interstitial fibrosis score (P = 0.016), tubular atrophy score (P = 0.010) and total renal chronicity score (P = 0.010), and were more likely to be accompanied by focal segmental glomerulosclerosis (P = 0.014). Higher SAb level was associated with the total renal chronicity score (odds ratio per 100 RU/mL, 1.16; 95% confidence interval 1.01-1.33; P = 0.033). Conclusions. PLA2R-associated MN patients with seropositive PLA2R antibody but negative PLA2R deposits in the glomeruli by IF-F have higher levels of SAb and worse clinicopathological manifestations compared with their double-positive counterparts. IHC-P can be an alternative technique to reveal PLA2R glomerular deposits.
引用
收藏
页码:2216 / 2223
页数:8
相关论文
共 50 条
  • [31] Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond
    Murtas, Corrado
    Bruschi, Maurizio
    Spinelli, Sonia
    Kajana, Xhuliana
    Verrina, Enrico E.
    Angeletti, Andrea
    Caridi, Gianluca
    Candiano, Giovanni
    Feriozzi, Sandro
    Prunotto, Marco
    Ghiggeri, Gian Marco
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [32] PLA2R Autoantibodies and Recurrent Membranous Nephropathy after Transplantation
    Stahl, Rolf
    Hoxha, Elion
    Fechner, Kai
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05): : 496 - 498
  • [33] Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy
    Burbelo, Peter D.
    Joshi, Megha
    Chaturvedi, Adrija
    Little, Dustin J.
    Thurlow, John S.
    Waldman, Meryl
    Olson, Stephen W.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (01): : 208 - 217
  • [35] Nomogram for thromboembolic events in primary membranous nephropathy associated with PLA2R antibody
    Zihan Zhai
    Yanhong Guo
    Lu Yu
    Yulin Wang
    Liuwei Wang
    Qiuhong Li
    Yapei Yuan
    Lin Tang
    Scientific Reports, 15 (1)
  • [36] Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy
    Burbelo, Peter D.
    Beck, Laurence H., Jr.
    Waldman, Meryl
    JOURNAL OF IMMUNOLOGICAL METHODS, 2017, 444 : 17 - 23
  • [37] Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
    Ruiying Chen
    Jia Wang
    Qionghong Xie
    Jianming Zheng
    Shaojun Liu
    Jun Xue
    Chuanming Hao
    BMC Nephrology, 23
  • [38] Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
    Chen, Ruiying
    Wang, Jia
    Xie, Qionghong
    Zheng, Jianming
    Liu, Shaojun
    Xue, Jun
    Hao, Chuanming
    BMC NEPHROLOGY, 2022, 23 (01)
  • [39] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2090 - I2091
  • [40] The Efficacy of an Initial Prednisone Monotherapy Regimen on PLA2R-associated Idiopathic Membranous Nephropathy
    Bai, Yu
    Liu, Jing
    Duan, Yajuan
    Liu, Wenhu
    Diao, Zongli
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (03): : 404 - 406